Hepatitis C virus (HCV) shows substantial nucleotide sequence diversity distributed throughout the viral genome, with many variants showing only 68 to 79 % overall sequence similarity to one another. Phylogenetic analysis ofnucleofide sequences derived from part of the gene encoding a non-structural protein (NS-5) has provided evidence for six major genotypes of HCV amongst a worldwide collection of 76 samples from HCV-infected blood donors and patients with chronic hepatitis. Many of these HCV types comprised a number of more closely related subtypes, leading to a current total of 11 genetically distinct viral populations. Phylogenetic analysis of other regions of the viral genome produced relationships between published sequences equivalent to those found in NS-5, apart from the more highly conserved 5' non-coding region in which only the six major HCV types, but not subtypes, could be differentiated. A new nomenclature for HCV variants is proposed in this communication that reflects the twotiered nature of sequence differences between different viral isolates. The scheme classifies all known HCV variants to date, and describes criteria that would enable new variants to be assigned within the classification as they are discovered.
Introduction
Infection with hepatitis C virus (HCV) has been identified as the major cause of post-tranfusion non-A, non-B hepatitis (Choo et al., 1989; Kuo et al., 1989) . The virus has a positive-sense, ssRNA genome approximately 10 kb in length, with similarities in genome organization and some sequence homology with pestiviruses and flaviviruses Brown et al., 1992) . Different isolates of HCV show substantial nucleotide sequence variability distributed throughout the viral genome (Okamoto et al., 1991 (Okamoto et al., , 1992b . Regions The nucleotide sequences obtained in this investigation have been submitted to GenBank and assigned the accession nmnbers L23435 to L23475.
encoding the putative envelope protiens [El, E2/nonstructural protein 1 (NS-1)] are the most variable Hijikata et al., 1991) , whereas the 5' non-coding region (5' NCR) is the most conserved Cha et al., 1991 ; Okamoto et al., 1990; Bukh et al., 1992a) . Comparison of published sequences of HCV has led to the identification of a number of distinct virus' types', that may differ from each other by as much as 33 % over the whole viral genome (Choo et aI., 1991 ; Okamoto et al., 1991; Chan et al., 1992; Mori et al., 1992; Okamoto et al., 1992b) .
This degree of sequence variability is sufficient to alter the antigenic and biological properties of members of this virus group significantly. The immunoreactive region of the NS-4 protein is highly variable so that most epitopes are type-specific (Simmonds et al., 1993b) . This leads to a substantial reduction in the effectiveness of antibody assays based on this protein for serological diagnosis of infection with divergent HCV types (Chan et al., 1991; McOmish et al., 1993; Kato et al., 1991; Cha et al., 1992) ; however, second generation assays containing multiple antigens are more broadly reactive. Samples found positive by second generation assays, but negative with first generation assays, have proved to be new viral types (Cha et al., 1992) . Whether or not other HCV variants remain undetected using the extensive battery of antigens currently employed remains an area of intensive investigation.
Variability in the envelope region is even greater so that neutralizing antibodies might be type-specific and allow multiple infection with different HCV variants in re-exposed individuals. Finally, there is some evidence for variation in the course of infection associated with different HCV variants and in response to treatment with interferon (Kanai et al., 1992; Yoshioka et al., 1992; Takada et al., 1992a; Pozzato et al., 1991) . If these results are confirmed in larger studies this would indicate an important role for identification of genotype in the pretreatment assessment of patients with chronic hepatitis.
We have previously carried out phylogenetic analyses of nucleotide sequences amplified in the region of the genome encoding the core protein, and parts of the NS-3 and NS-5 proteins (Chan et al., 1992) . Although different degrees of variability were found in various parts of the genome, analysis of each produced trees topologically identical to those obtained upon analysis of complete genome sequences. Based on these initial results, we proposed that HCV might usefully be classified into three major HCV types, with variants designated type 1 and type 2 each comprising two more closely related subtypes (Chan et al., 1992) .
In this communication we have carried out phylogenetic analysis of a 222 bp fragment of NS-5 between nucleotide positions 7975 and 8196 (numbered as in Choo et al., 1991) . This region was amplified from plasma or serum of 41 infected individuals using relatively well conserved primers (Enomoto et al., 1990) , and compared with 35 published NS-5 sequences from other laboratories.
Methods
Samples. Plasma or serum samples were obtained from 41 HCVinfected blood donors or NANBH patients from a variety of geographical regions (Table 1) . Sequences obtained in this study were compared with 35 previously published sequences listed in Table 1 .
Nucleotide sequence analysis. To obtain sequences in the NS-5 region, viral RNA was reverse transcribed and amplified in a single reaction using primers thought to be highly conserved amongst different variants of HCV (Enomoto et al., 1990) . For some sequences, a second PCR was carried out with primers 554 and 555 (Chan et al., 1992) in combination with two new primers, 122 (sense orientation; 5" CTC AAC CGT CAC TGA GAG AGA CAT 3') and 123 (antisense; 5' GCT CTC AGG TTC CGC TCG TCC TCC 3"). Product DNA was phosphorylated, purified and cloned into the SmaI site of pUC19 (Yanisch-Perron et al., 1985) following the procedures described elsewhere . Alternatively, amplified DNA was purified and directly sequenced as previously described (Simmonds et al., 1990; Cha et al., 1992) . These methods allowed comparison of a 222 bp fragment of DNA homologous to positions 7975 to 8196 in the prototype virus (numbered as in Choo et al., 1991) . Nucleotide sequence comparisons. Nucleotide sequences were aligned using the CLUSTAL V program (Higgins et al., 1992) as implemented in the GDE sequence analysis package. Distances between pairs of sequences were estimated using the DNADIST program of the PHYLIP package (version 3.4) kindly provided by Dr J. Felsenstein (Felsenstein, 1991) , using a model which allows different rates of transition and transversion and different frequencies of the four nucleotides (Felsenstein, 1991) . Phylogenetic trees were constructed using the neighbour-joining algorithm on the previous sets of pairwise distances (Saitou & Nai, 1987) using the PHYLIP program, NEIGHBOR. Equivalent phylogenetic relationships were also found in a maximum likelihood analysis (PHYLIP program DNAML; data not shown), and 2000 bootstrap replicates of neighbour-joining trees (PHYLIP programs SEQBOOT and CONSENSE).
Results and Discussion

Phylogenetic analysis of NS-5 sequences
RNA was extracted from 41 serum or plasma samples from a wide range of HCV-infected individuals from several locations (U.S.A., Europe, South America, South Africa, Middle East and Far East; Table 1), and amplified using previously published NS-5-specific primers (Enomoto et al., 1990) . The region was chosen for phylogenetic analysis because it is sufficiently variable to allow differentiation between different isolates of HCV, and there is already a large amount of comparative sequence data; 35 further sequences have been published by other groups and were included in the analysis described here.
Pairwise comparisons revealed a wide range of evolutionary distances amongst the 76 HCV variants analysed. Using Felsenstein's model of molecular evolution (Felsenstein, 1991) , distances ranged from 0.01 (between T9 and T10; Mori et al., 1992) to 0"85 (EG-7 to K-2a; Simmonds et al., 1993a; Enomoto et al., 1990) . However, the distribution of distances was confined to three separate and non-overlapping groups (Fig. 1 a) . The first ranged from 0.38 to 0.84 (mean 0-543), the second showed intermediate evolutionary distances of Hepatitis C virus." six major genotypes 2393 0'16 to 0"32 (mean 0.248) and the third showed a range of 0 to 0.12 (mean of 0.061). In none of the 2850 pairwise comparisons were distances of 0.14 to 0" 16 or 0.34 to 0-38 found. Furthermore, in no case did the mean value of each distribution _+3 S.D. overlap with any other, indicating that at least 99.7 % of evolutionary distances would be expected to fall within these non-overlapping ranges.
Three levels of sequence diversity may also be observed in a phylogenetic tree of NS-5 sequences (Fig. 2) . This analysis shows six major groupings of sequences that are approximately equally divergent from each other. Within some of the major groupings, two or three clusters of more closely related variants are observed.
Mean evolutionary distances between variants in different major branches ranged from 0.41 to 0.66 (Table  2) , and distances between the different clusters within the major branches were in all cases substantially lower (0.20 to 0-30). Using the grouping of sequences suggested by Fig. 2 , the distribution of mean differences (Table 2) lies entirely within the overall distribution of distances derived from pairwise comparison of individual sequences (Fig. 1) .
Based on these results, we propose a classification of HCV that incorporates the three clearly distinct levels of HCV sequence variability. In this scheme, the major groupings of sequence variants are designated HCV ' types', whereas the more closely related groups observed within some types are termed 'subtypes'. In Fig. 2 , we have labelled the HCV types in Arabic numbers, and the subtypes by lower case letters, in order of discovery. Thus the genotype of the variant, HCV-1, first cloned by Choo et al. (1991) is assigned as type la (sequence no. 1).
In this comparison, we have included fragments from a number of other complete genomic sequences. HCV-H (no. 6) shows 95.4 % nucleotide sequence identity with HCV-1 over the length of the genome, and is also classified as type la in this scheme. Several of the more divergent Japanese and Taiwanese sequences (e.g. HCV-BK, HCV-J and T; nos. 17, 18 and 19) that show 78 to 79 % overall sequence similarity with HCV-1 fall into a separate phylogenetic group labelled type lb in Fig. 2 . The most divergent complete genomic sequences HC-J6 and HC-J8 (nos. 36 and 49) that show only 67.1 to 68-3 % sequence similarity with types la and lb cluster in separate groups, and have been designated types 2a and 2b respectively.
The group labelled 3a contains NS-5 sequences from variants from Scottish blood donors previously described as type 3 (nos. 61, 62, 63 and 64; Chan et al., 1992) , and variants found in NANBH patients from Thailand described by the authors as type V (nos. 59 and 60; Mori et al., 1992) . Our phylogenetic analysis of further variants from Thailand originally termed type VI (nos. 67 and 68) indicated that they were a further subtype of type 3 rather than a major new HCV type. The six groups, la, lb, 2a, 2b, 3a and 3b, account for all of the previously published NS-5 sequences of HCV and the majority of those obtained in this study. However, from Fig. 2 we can provisionally assign the remainder of the sequences as new types and subtypes of HCV. Sequences amplified from Lebanese NANBH patients (nos. 32 and 33) correspond to a further subtype of type 1, and sequences from NANBH patients in Argentina and Italy, and a Scottish blood donor (nos. 50 to 53) cluster together as a new subtype of type 2.
Variants in the group labelled 4a are all from Egypt. Their status as a new genotype is consistent with our previous analysis of sequences in the core region from these blood donors, where we found that they grouped separately from those of types 1, 2 and 3 (Simmonds et al., 1993a) . The group labelled 5a contains variants previously designated as group V on the basis of previous sequence analysis of the 5' NCR and NS-5 regions (Cha et al., 1992) . The sequence labelled type 6a (no. 76) was obtained from a Hong Kong blood donor. This variant also differs from all other HCV sequences in the 5' NCR by the presence of a unique 2 bp insertion at position -143 (Simmonds et al., 1993a) . Sequences elsewhere in the genome have yet to be examined.
Comparison of the nomenclature shown in Fig. 2 with those originating from other laboratories reveals both similarities and differences (Table 3) . Alternative classifications have identified the existence of distinct genotypes, but often do not recognize the two-tiered range of sequence differences. For example, a scheme described by Okamoto et al. (1991 Okamoto et al. ( , 1992b and Mori et al. (1992) describes HCV types I, II, III, IV, V and VI which correspond to types la, lb, 2a, 3a and 3b respectively. Cha et al. (1992) described five groups of HCV variants, where I corresponds to la, II to lb, III to 2a, 2b and 2c, IV to 3a and 3b to V to type 5a. Consequently, these classifications are difficult to extend to incorporate type lc, 2c and possibly other new subtypes as they are discovered. Differences between the various schemes have contributed to many of the difficulties in comparing results from different research centres.
Identification of HCV variants
The largest collections of comparative sequence data are currently in the NS-5 region analysed here and in the 5' NCR. The NS-5 region is a useful region for virus identification because it may be amplified readily from plasma or serum of infected individuals using published primer sequences (Enomoto et al., 1990) , and because it is sufficiently variable that both types and subtypes may be identified. Although in principle other parts of the coding region of the viral genome may be equally informative, the current lack of comparative sequence would prevent comparison with the newer sequence variants (types 4 to 6).
Phylogenetic analysis provides the most accurate reconstruction of evolutionary relationships and distances between HCV sequences. However this approach is computationally intensive, and it is easier simply to calculate the proportion of matched nucleotides upon each pairwise comparison of sequences. These (uncorrected) sequence similarities do not allow for multiple substitutions and can greatly underestimate the true extent of divergence between dissimilar sequences (Fig.  1 b) . Sequence similarities between different isolates of the same HCV type (88 to 100%) closely match corresponding evolutionary distances (0 to 0.12), whereas those between subtypes (74 to 86 %) and between types (56 to 72%; Fig. l b) and 0.38 to 0"86; Fig. la) . However, even these uncorrected distances produce three non-overlapping (although compressed) distributions that exactly reproduce the type/subtype distinction derived from evolutionary analysis. (1992) ; Tsukiyama-Kohara: Tsukiyama Kohara et al. (1991) .
-~ Sequences numbered as in Table 1 . :~ NC, Sequences not classified by originating authors. Table 2 . Lower case letters indicate variable sites within sequence group, majority nucleotide shown.
Where no nucleotide forms a majority, IUPAC ambiguity codes are used: 'y', C or T; 'v', G, C or A; 'w', T or A. Other symbols: dots (.), identity with type 1 a sequence; hyphens represent gap introduced to preserve sequence alignment (type 6a); asterisks represent variable nucleotide positions where majority sequence is the same as type la. Sequences numbered as in Choo et al. (1991) .
The consensus sequences of each type and subtype described in this paper (Fig. 3) Fig. 3 , then it should not be assigned a new type description. It should be stressed that this type of classification must be regarded as provisional, and a more complete analysis of evolutionary relationships by phylogeny would be required to confirm sequence designations.
Sequence comparisons in other regions of the genome
We have carried out comparable analysis in the core region using sequences of HCV types 1 to 4 (Simmonds et al., 1993a) . This region also produces three nonoverlapping distributions of sequence similarities, although in this case, different HCV types show much greater similarities than for NS-5 (data not shown). Using the region of core shown in our previous analysis and sequences listed therein (positions 29 to 269; Simmonds et al., 1993 a) , we found similarities between HCV types ranged from 81 to 89% whereas those between subtypes were from 91 to 94%. Sequence similarities of greater than 94% are found between different isolates of the same HCV type.
All of the six major types of HCV may also be identified by comparison of sequences in the 5' NCR (Simmonds et al., 1993a; Bukh et al., 1992b; Cha et al., 1992) , although often only relatively few nucleotide differences exist between them. Nucleotide sequence variability in the 5' NCR also differs from that found in the coding regions in that there are no reliable sequence polymorphisms in this region that allow the differentiation of HCV subtypes. HCV types la, lb and lc show essentially the same sequences in the 5' NCR, as do types 2a and 2c (Chan et al., 1992; Cha et al., 1992; Simmonds et al., 1993a) . At this stage, it appears that reliable differentiation into subtypes will remain dependent on analysis of coding regions.
Origins of HCV types
The samples used in this study were from either blood donors or patients with non-A, non-B hepatitis. Although a comprehensive geographical survey of HCV types was not attempted, there do appear to be differences in their distribution in different countries. HCV types 1 and 2 have been found in almost all countries tested, including those in Europe, North America and the Far East (Li et al., 1991 ; Takada et al., 1992a, b; Cha et al., 1992; Kato et al., 1991 ; Chan et aI., 1992) . Although HCV type 3 has not been found in Japan, it has been frequently reported from Europe (Chan et al., 1992) , U.S.A. (Lee et al., 1992) , Thailand (Mori et al., 1992) and India (unpublished observations). In the Middle East, almost all anti-HCV-positive individuals identified on blood donor screening are infected with type 4 , which has also been detected in NANBH patients in Zaire (Bukh et al., 1992b) . HCV types 5 and 6 show highly restricted geographical distributions, being apparently confined to South Africa and Hong Kong respectively (Cha et al., 1992; Simmonds et al., 1993a) . At this stage it is difficult to interpret the significance of these different distributions of variants, as the epidemiology of virus spread is at present poorly understood.
In summary, we have used a series of comparative methods to establish sequence relationships between HCV variants. The system is internally consistent, and the phylogenetic and numerical comparison methods described here will facilitate the assigment of new sequence variants as they are discovered. The uniform nomenclature proposed in Table 2 would, if adopted, considerably clarify comparative evaluation of results from different laboratories. This requirement will undoubtedly increase as more is understood about the important biological and serological differences that have been found to exist between the different variants of HCV.
